Ad
Monday, 13 January 2020
Novartis to speed access to $10 billion heart drug via NHS deal
Novartis and Britain's National Health Service (NHS) on Monday announced a pact that will clear the way for accelerated review by the country's health watchdog NICE for heart drug inclisiran, which could make it broadly available as soon as 2021.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment